Heart failure-inducible suppression of protein phosphatase 1β partially prevents cardiac remodeling in experimental pressure overload-induced heart failure
        The bulletin of the Yamaguchi Medical School Volume 64 Issue 1-2
        Page 1-12
        
    published_at 2017
            Title
        
        Heart failure-inducible suppression of protein phosphatase 1β partially prevents cardiac remodeling in experimental pressure overload-induced heart failure
        
        
    
            Abstract
        
        Aberrant increases in protein phosphatase 1(PP1) activity have been shown to be associated with inefficient sarcoplasmic reticulum Ca^{2+} cycling, leading to cardiac dysfunction in the failing heart. In the present study, we investigated whether BNP promoter-inducible suppression of PP1β would ameliorate progression of pressure overload-induced heart failure in mice, a clinically relevant animal model. An Adeno-associated virus 9 (AAV9) vector encoding PP1βshRNA and a negative control (NC) shRNA driven by a brain natriuretic peptide (BNP) promoter with an emerald green fluorescent protein expression (EmGFP) cassette were used to test the hypothesis. AAV9 vectors (AAV9-BNP-EmGFP-PP1βshRNA and AAV9-BNP-EmGFP-NCshRNA) were introduced into the in vivo heart via the tail vein injection (4x10^{11} GC/mice) in 8-week-old C57BL6J mice, followed by transverse aortic constriction (TAC) 2 weeks after the AAV9 vector injection. Post TAC cardiac function was sequentially assessed every 2 week by echocardiography, followed by hemodynamic assessment at 1 month. AAV9-BNP-EmGFP-PP1βshRNA treatment suppressed myocardial PP1β expression by 15% compared with the NCshRNA group (p<0.001). The fractional shortening (%FS) of the left ventricle in the PP1βshRNA-treated group was significantly larger than the NCshRNA-treated group (21%±1.0% vs. 15%±0.01, p<0.01). The ratios of heart weight (HW) / body weight (BW) and lung weight (LW) / BW in the PP1βshRNA group were significantly smaller than those of the NCshRNA group (HW/BW: 9.20±0.49 vs. 10.6±0.45 mg/g
        
    
                
                    Creators
                
                    Shiraishi Kozo
                
                
            
            
                
                    Creators
                
                    Ikeda Yasuhiro
                
                
            
            
                
                    Creators
                
                    Miyazaki Yosuke
                
                
            
            
                
                    Creators
                
                    Fujimoto Shizuka N.
                
                
            
            
            
                
                    Creators
                
                    Miura Toshiro
                
                
            
            
            
    
        
            Source Identifiers
        
                    [PISSN] 0513-1812
                    [NCID] AA00594272
    
    
            Creator Keywords
        
            protein phosphatase 1β(PP1β)
            adeno-associated virus 9 (AAV9) vector
            brain natriuretic peptide (BNP) promoter
            AAV9-BNP-EmGFP-PP1βshRNA
            transverse aortic constriction (TAC)
    
        
            Languages
        
            eng
    
    
        
            Resource Type
        
        departmental bulletin paper
    
    
        
            Publishers
        
            Yamaguchi University School of Medicine
    
    
        
            Date Issued
        
        2017
    
    
        
            File Version
        
        Version of Record
    
    
        
            Access Rights
        
        open access
    
    
        
            Schools
        
            大学院医学系研究科(医学)
    
                
